Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
47
PRVCF Quote, Financials, Valuation and Earnings
Last price:
$0.0100
Seasonality move
:
-3.25%
Day range:
$0.0130 - $0.0131
52-week range:
$0.0106 - $0.0436
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
190K
Avg. volume:
90K
1-year change:
-20.25%
Market cap:
$7.4M
Revenue:
--
EPS (TTM):
-$0.00
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, PreveCeutical Medical, Inc. has -- downside to fair value with a price target of -- per share.
PRVCF vs. S&P 500
-
Over the past 5 trading days, PreveCeutical Medical, Inc. has underperformed the S&P 500 by -35.2% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
PreveCeutical Medical, Inc. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PreveCeutical Medical, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter PreveCeutical Medical, Inc. reported revenues of --.
Earnings Growth
-
PreveCeutical Medical, Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter PreveCeutical Medical, Inc. reported earnings per share of -$0.00.
Enterprise value:
10.7M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$6.2K
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -$6.2K | -- | -$2.6K | |
| Operating Income | -- | -- | -- | -- | -$560.3K | |
| EBITDA | -- | -- | -- | -- | -$557.7K | |
| Diluted EPS | $0.00 | -- | -$0.00 | -- | -$0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $211.8K | |
| Total Assets | -- | -- | -- | -- | $327.8K | |
| Current Liabilities | -- | -- | -- | -- | $5.6M | |
| Total Liabilities | -- | -- | -- | -- | $5.6M | |
| Total Equity | -- | -- | -- | -- | -$5.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -$380.2K | |
| Cash From Investing | -- | -- | -- | -- | $39.4K | |
| Cash From Financing | -- | -- | -- | -- | $432.3K | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
PRVCF
Sector
Market Cap
$7.4M
--
Price % of 52-Week High
29.82%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
-20.25%
--
Beta (5-Year)
0.617
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0179
200-day SMA
Sell
Level
$0.0225
Bollinger Bands (100)
Sell
Level
0.023 - 0.023
Chaikin Money Flow
Sell
Level
-143K
20-day SMA
Sell
Level
$0.0186
Relative Strength Index (RSI14)
Sell
Level
36.9475
ADX Line
Sell
Level
13.2944
Williams %R
Buy
Level
-99.2537
50-day SMA
Sell
Level
$0.0216
MACD (12, 26)
Sell
Level
-0.0017
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
7.8M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PreveCeutical Medical, Inc. engages in licensing, branding, and marketing of nutraceutical and wellness products. The company was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman, and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.
Stock Forecast FAQ
In the current month, PRVCF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PRVCF average analyst price target in the past 3 months is --.
-
Where Will PreveCeutical Medical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that PreveCeutical Medical, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About PreveCeutical Medical, Inc.?
Analysts are divided on their view about PreveCeutical Medical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PreveCeutical Medical, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is PreveCeutical Medical, Inc.'s Price Target?
The price target for PreveCeutical Medical, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PRVCF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PreveCeutical Medical, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PRVCF?
You can purchase shares of PreveCeutical Medical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PreveCeutical Medical, Inc. shares.
-
What Is The PreveCeutical Medical, Inc. Share Price Today?
PreveCeutical Medical, Inc. was last trading at $0.0100 per share. This represents the most recent stock quote for PreveCeutical Medical, Inc.. Yesterday, PreveCeutical Medical, Inc. closed at $0.0130 per share.
-
How To Buy PreveCeutical Medical, Inc. Stock Online?
In order to purchase PreveCeutical Medical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get PRVCF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PRVCF
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
--
--
Price / LTM sales
--
--
Growth Metrics
PRVCF
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
PRVCF
Sector
Profitability FY 2024
-$7.4K
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
8
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
PRVCF
Sector
Total cash
$74.5K
--
Short term investments
--
--
Total assets
$156.9K
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
